Throughout 2021, the ATS Public Advisory Roundtable (PAR) is hosting its updated and tenth annual “Lung Disease Week at the ATS” series, a society-wide initiative that recognizes the many lung and airway disorders for which ATS PAR member organizations provide support and guidance to patients and their families. For a series of one-week periods, ATS PAR brings patient issues to the front and center of the Society’s agenda. Working with its PAR partners, the ATS develops, aggregates, and hosts links to patient-centered disease-specific content on its web site.
PAR Partners Michele Manion - PCD Foundation Siri Vaeth - Cystic Fibrosis Research Institute
ATS Member DorAnne Donesky, PhD
Environment & Lung Health August 15-21
PAR Partners Kim Parham - Go2 Foundation for Lung Cancer Tonya Winders - Allergy and Asthma Network
ATS Members Patrick Belvitch, MD Jean Marie Bruzezzi, PhD
Lung Scarring & Fibrosis September 5-11
PAR Partners Donna Appell - HPS Network Jennifer Mefford - Pulmonary Fibrosis Foundation
ATS Member Deji Adegunsoye, MD
Critical Care & Hospitalization October 3-9
PAR Partners Serese Marotta - Families Fighting Flu Tonya Winders - Allergy and Asthma Network
ATS Members Catherine Chen, MD Ann Jennerich, MD
Caregivers & Caregiving November 7-13
PAR Partners Siri Vaeth - Cystic Fibrosis Research, Inc Kari Rosbeck - Tuberous Sclerosis Alliance
ATS Member Lynn Reinke, PhD Tirsa M. Ferrer Marrero, MD FCCP
For more information on Lung Disease Week at the ATS, please contact Courtney L. White, CAE, Director of Patient Outreach & Tobacco Control or (212) 315-8640.
Disclaimer:"The ATS Lung Disease Week Web site is designed for educational purposes only. You should not rely on this information as a substitute for personal medical attention, a diagnosis from a physician, or direct medical care. If you are concerned about your health or that of a family member, please consult your family's healthcare provider immediately. Do not wait for a response from our members, staff or partners."
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
AMERICAN THORACIC SOCIETY 25 Broadway New York, NY 10004 United States of America
